Conference Program Home
  My Program

All Times EDT

CC = Walter E. Washington Convention Center   M = Marriott Marquis Washington, DC
* = applied session       ! = JSM meeting theme

Activity Details

53 * ! Sun, 8/7/2022, 4:00 PM - 5:50 PM CC-143B
Considerations in Selection of the Appropriate Intercurrent Event Strategies for Estimands: Hypothetical vs. Composite vs. Treatment Policy — Topic Contributed Papers
Biopharmaceutical Section, ENAR, Biometrics Section
Organizer(s): Pilar Lim, Janssen Research & Development, LLC
Chair(s): Elena Polverejan, PhD, Janssen Research & Development, LLC
4:05 PM Hypothetical Conversations: Which Estimand Strategies Are Clinically Relevant When Trial Participants Do Not Follow Clinically Relevant Protocol Guidelines?
Bohdana Ratitch, Bayer Inc., Canada; Katrin Roth, Bayer
4:25 PM Treatment Policy Estimation – Hidden Sources of Bias
Michael Paul O'Kelly, IQVIA; Sylvia Siying Li, IQVIA
4:45 PM Targeting Composite Estimands Using Trimmed Means
Alex Ocampo, Novartis Pharma AG
5:05 PM Discussant: Hsien-Ming 'James' Hung, PhD, U. S. FDA
5:25 PM Discussant: Yongming Qu, PhD, Lilly
5:45 PM Floor Discussion